PreveCeutical Medical Inc. (PRVCF)
USD 0.02
(6.38%)
USD 0.02
(6.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 3031.00 | 15.45 Thousand |
| Cost of Revenue | 9856.00 | 9891.00 | 5091.00 | 75.16 Thousand | 779.00 | 4723.00 |
| Gross Profit | -9856.00 | -9891.00 | -5091.00 | -75.16 Thousand | 2252.00 | 10.72 Thousand |
| Operating Expenses | 963.12 Thousand | 1.08 Million | 897.85 Thousand | 2.16 Million | 3.5 Million | 6.93 Million |
| Selling, General and Administrative Expenses | 813.02 Thousand | 1 Million | 720.91 Thousand | 1.77 Million | 1.37 Million | 3.62 Million |
| Research and Development Expenses | 92.45 Thousand | 78.42 Thousand | 171.84 Thousand | 315.14 Thousand | 1.96 Million | 3.27 Million |
| Other Expenses | 57.64 Thousand | - | - | 23.02 Thousand | -345.78 Thousand | -1.57 Million |
| Cost and Expenses | 963.12 Thousand | 1.09 Million | 897.85 Thousand | 2.16 Million | 3.51 Million | 6.94 Million |
| Operating Income | -963.12 Thousand | -1.09 Million | -897.85 Thousand | -2.14 Million | -3.5 Million | -6980.22 |
| Interest Expense | 309.52 Thousand | 237.27 Thousand | 466.89 Thousand | 640.04 Thousand | 578.68 Thousand | 549.07 Thousand |
| Income Tax Expense | - | -1.00 | -20.47 Thousand | -6150.00 | -7875.00 | -40.34 Thousand |
| Earnings before Tax | -1.27 Million | -1.48 Million | -1.74 Million | -3.8 Million | -3.58 Million | -11.92 Million |
| Net Income | -1.27 Million | -1.48 Million | -1.72 Million | -3.8 Million | -3.57 Million | -11.88 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.04 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.04 |
| Weighted Average Shares Outstanding | 535.49 Million | 521.78 Million | 507.95 Million | 455.68 Million | 395.74 Million | 318.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 535.3 Million | 521.78 Million | 507.95 Million | 455.68 Million | 395.74 Million | 318.88 Million |
| Gross Margin | - | - | - | - | 0.74 | 0.69 |
| EBIT Margin | - | - | - | - | -1099.57 | -548.11 |
| Profit Margin | - | - | - | - | -1180.77 | -769.10 |
| EBITDA | -905.47 Thousand | -1.02 Million | -829.83 Thousand | -2.06 Million | -2.83 Million | -11.33 Million |
| Earnings Before Tax Margin | - | - | - | - | -1157.16 | -0.45 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 2522.00 | 2499.00 | 9856.00 | 2450.00 | 2436.00 | 2481.00 |
| Gross Profit | -2522.00 | -2499.00 | -9856.00 | -2450.00 | -2436.00 | -2481.00 |
| Operating Expenses | 273.02 Thousand | 139.61 Thousand | 953.26 Thousand | 350.24 Thousand | 153.12 Thousand | 160.07 Thousand |
| Selling, General and Administrative Expenses | 252.46 Thousand | 119.32 Thousand | - | 326.22 Thousand | 87.66 Thousand | 139.89 Thousand |
| Research and Development Expenses | 20.55 Thousand | 20.28 Thousand | - | 24.01 Thousand | 52.38 Thousand | 20.18 Thousand |
| Other Expenses | 27.48 Thousand | - | - | - | - | - |
| Cost and Expenses | 275.54 Thousand | 142.1 Thousand | 963.12 Thousand | 352.69 Thousand | 153.12 Thousand | 162.56 Thousand |
| Operating Income | -275.54 Thousand | -142.11 Thousand | -963.12 Thousand | -352.7 Thousand | -153.12 Thousand | -162.56 Thousand |
| Interest Expense | 81.92 Thousand | 80.94 Thousand | 309.52 Thousand | 79.68 Thousand | 79.7 Thousand | 76.77 Thousand |
| Income Tax Expense | -2.00 | 1.00 | 4.00 | -41.36 Thousand | 79.7 Thousand | -1.00 |
| Earnings before Tax | -361.96 Thousand | -235.4 Thousand | -1.27 Million | -423.06 Thousand | -239.63 Thousand | -230.57 Thousand |
| Net Income | -361.96 Thousand | -235.4 Thousand | -1.27 Million | -423.06 Thousand | -239.63 Thousand | -230.57 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | - | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | - | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 536.93 Million | 535.3 Million | 535.3 Million | 535.3 Million | 535.3 Million | 535.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 536.93 Million | 535.3 Million | 535.3 Million | 535.3 Million | 535.3 Million | 535.3 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -273.02 Thousand | -139.61 Thousand | - | -350.25 Thousand | -150.68 Thousand | -160.08 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
FIEMIND
BRNGF
VIKASLIFE
9959
ITRG
NYKAA